Retreatment of Recurrent Tumors Using Proton Therapy
Patients will be stratified by treatment site (Head and Neck, Thorax, Abdomen, Pelvis,
Extremities) and by treatment volume (low volume, high volume) for a total of 10 strata.
This study will be done in two phases. In the first phase, feasibility will be established
using the primary objectives set below. The second phase will begin no earlier than 90 days
after the last patient in the initial phase has completed treatment in each strata and once
feasibility has been verified. The secondary objectives will serve as the objectives for the
second phase of the study.
The study is infeasible if patient cannot be given treatment. Patient is unable to tolerate 15% treatment. patient is unable to complete all of his/her treatments within 10 days of estimated date of treatment completion.
John Plastaras, MD, PhD
Abramson Cancer Center of the University of Pennsylvania
United States: Institutional Review Board
|Procure||Oklahoma City, Oklahoma 73142|
|Abamson Cancer Center of the University of Pennsylvania||Philadelphia, Pennsylvania 19104|
|ProCure Proton Therapy Center||Warrenville, Illinois 60555|